{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:26:28Z","timestamp":1787635588979,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"name":"Chidren\u2019s Cancer Institute"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Ewing Sarcoma (ES) is a small, round, blue cell tumor (SRBCT) characterized by a chromosomal translocation between chromosomes 11 and 22 in ~85% of cases, alongside immunohistochemical (IHC) expression of the surface glycoprotein CD99. Despite advancements in molecular diagnostics, low-income countries continue to face challenges in tumor classification and identification of fusion partners.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study retrospectively analyzed pathology reports from 396 patients enrolled in the Latin American Cooperative Group (GALOP) trial, with data collected until December 2021. CD99 positivity or molecular confirmation of EWSR1 translocation were required for inclusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>IHC marker selection varied across pathology units, reflecting differences in national guidelines. FLI1 was assessed in 45.5% of cases, VIM in 40.4%, and NKX2-2 in 14.9%. The most common complementary markers included desmin (60.1%), myogenin (47.5%), LCA\/CD45 (51.5%), and synaptophysin (44.9%). EWSR1 translocation confirmation was performed in 74 patients (18.6%) using FISH and\/or PCR. Molecular testing was more frequent in Argentina (73%), while Brazil, Chile, and Uruguay reserved it for diagnostically uncertain cases. Ki-67 was assessed in 70 cases, with most showing a high proliferation index (&gt;30%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These findings underscore the need for continued collaboration to standardize diagnostic approaches across Latin America, aiming to improve treatment outcomes for ES patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003145","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:00:11Z","timestamp":1765227611000},"page":"6-12","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Pathologic and Molecular Diagnosis of Ewing Sarcoma: A Multicenter Analysis From the Latin American Cooperative Group Trial"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7958-1279","authenticated-orcid":false,"given":"Andr\u00e9 T.","family":"Brunetto","sequence":"first","affiliation":[{"name":"Children\u2019s Cancer Institute (ICI)"},{"name":"National Science and Technology Institute for Children\u2019s Cancer Biology and Pediatric Oncology \u2013 INCT BioOncoPed"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauro J.","family":"Gregianin","sequence":"additional","affiliation":[{"name":"Children\u2019s Cancer Institute (ICI)"},{"name":"National Science and Technology Institute for Children\u2019s Cancer Biology and Pediatric Oncology \u2013 INCT BioOncoPed"},{"name":"Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA)"},{"name":"Hospital de Cl\u00ednicas in Porto Alegre (HCPA), Federal University of Rio Grande do Sul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialva","family":"Sinigaglia","sequence":"additional","affiliation":[{"name":"Children\u2019s Cancer Institute (ICI)"},{"name":"National Science and Technology Institute for Children\u2019s Cancer Biology and Pediatric Oncology \u2013 INCT BioOncoPed"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie F.C.S.","family":"Pestilho","sequence":"additional","affiliation":[{"name":"Children\u2019s Cancer Institute (ICI)"},{"name":"National Science and Technology Institute for Children\u2019s Cancer Biology and Pediatric Oncology \u2013 INCT BioOncoPed"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Rose","sequence":"additional","affiliation":[{"name":"Hospital de Pediatria SAMIC Prof\u00b0 \u201cDr Juan Garrahan,\u201d Buenos Aires"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Villarroel","sequence":"additional","affiliation":[{"name":"Hospital Dr. Luis Calvo Mackenna, Santiago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Castillo","sequence":"additional","affiliation":[{"name":"Pediatric Hemato-Oncological Service, Fundaci\u00f3n P\u00e9rez Scremini, Pereira Rossell Hospital, Montevideo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"de Los Angeles","sequence":"additional","affiliation":[{"name":"Pediatric Hemato-Oncological Service, Fundaci\u00f3n P\u00e9rez Scremini, Pereira Rossell Hospital, Montevideo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline B.","family":"de Farias","sequence":"additional","affiliation":[{"name":"Children\u2019s Cancer Institute (ICI)"},{"name":"National Science and Technology Institute for Children\u2019s Cancer Biology and Pediatric Oncology \u2013 INCT BioOncoPed"},{"name":"Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Lopez Marti","sequence":"additional","affiliation":[{"name":"Hospital de Pediatria SAMIC Prof\u00b0 \u201cDr Juan Garrahan,\u201d Buenos Aires"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Alcalde","sequence":"additional","affiliation":[{"name":"Hospital Dr. Luis Calvo Mackenna, Santiago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"da Rosa Rivero","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas in Porto Alegre (HCPA), Federal University of Rio Grande do Sul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Roesler","sequence":"additional","affiliation":[{"name":"National Science and Technology Institute for Children\u2019s Cancer Biology and Pediatric Oncology \u2013 INCT BioOncoPed"},{"name":"Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA)"},{"name":"Department of Pharmacology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Rua Ramiro Barcelos, (ICBS, Campus Sa\u00fade \/UFRGS), Porto Alegre, RS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Collaborative Study Group of Ewing Family of Tumors EWING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"R1-20251230","first-page":"4307","article-title":"Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing\u2019s sarcoma and neuroepithelioma","volume":"48","author":"McKeon","year":"1988","journal-title":"Cancer Res"},{"key":"R2-20251230","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM198408303110907","article-title":"Chromosome translocation in peripheral neuroepithelioma","volume":"311","author":"Whang-Peng","year":"1984","journal-title":"N Engl J Med"},{"key":"R3-20251230","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/1097-0142(19910401)67:7<1886::AID-CNCR2820670712>3.0.CO;2-U","article-title":"MIC2 is a specific marker for Ewing\u2019s sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing\u2019s sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration","volume":"67","author":"Ambros","year":"1991","journal-title":"Cancer"},{"key":"R4-20251230","doi-asserted-by":"crossref","first-page":"70","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO classification of soft tissue tumours: news and perspectives","volume":"113","author":"Sbaraglia","year":"2021","journal-title":"Pathologica"},{"key":"R5-20251230","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13063-019-4026-8","article-title":"International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours\u2014EURO EWING 2012 Protocol","volume":"21","author":"Anderton","year":"2020","journal-title":"Trials"},{"key":"R6-20251230","doi-asserted-by":"crossref","first-page":"e28194","DOI":"10.1002\/pbc.28194","article-title":"Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04","volume":"67","author":"Chin","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20251230","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1200\/JCO.21.00358","article-title":"Phase III trial adding vincristine-topotecan-cyclophosphamide to the initial treatment of patients with nonmetastatic ewing sarcoma: a Children\u2019s Oncology Group report","volume":"39","author":"Leavey","year":"2021","journal-title":"J Clin Oncol"},{"key":"R8-20251230","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/bjc.2017.252","article-title":"GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish Sarcoma Group (GEIS)","volume":"117","author":"Mora","year":"2017","journal-title":"Br J Cancer"},{"key":"R9-20251230","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1200\/JCO.2011.41.5703","article-title":"Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children\u2019s Oncology Group","volume":"30","author":"Womer","year":"2012","journal-title":"J Clin Oncol"},{"key":"R10-20251230","doi-asserted-by":"crossref","first-page":"e28779","DOI":"10.1002\/pbc.28779","article-title":"The effect of hospital care volume on overall survival of children with cancer in Southern Brazil","volume":"68","author":"Arancibia","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20251230","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/pbc.25562","article-title":"Brazilian Collaborative On behalf of the Brazilian Collaborative Study Group of Ewing Family of Tumors EWING1 and the Brazilian Society of Pediatric Oncology SOBOPE. Carboplatin in the treatment of Ewing sarcoma: results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1","volume":"62","author":"Brunetto","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20251230","doi-asserted-by":"crossref","first-page":"e31554","DOI":"10.1002\/pbc.31554","article-title":"Ewing Sarcoma Investigators. Results of the Latin American Pediatric Oncology Group (GALOP-2011) trial for patients with localized Ewing sarcoma: a multicentric study of interval-compressed multiagent chemotherapy","volume":"72","author":"Gregianin","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"R13-20251230","doi-asserted-by":"crossref","first-page":"e31707","DOI":"10.1002\/pbc.31707","article-title":"Results of the Latin American Pediatric Oncology Group (GALOP) trial for patients with metastatic Ewing sarcoma: multicentric study of interval-compressed multiagent and metronomic chemotherapy","volume":"72","author":"Rose","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"R14-20251230","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/cncr.28657","article-title":"Sarcoma classification: an update based on the 2013 World Health Organization classification of tumors of soft tissue and bone","volume":"120","author":"Doyle","year":"2014","journal-title":"Cancer"},{"key":"R15-20251230","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1056\/NEJM199408043310503","article-title":"The Ewing family of tumors\u2014a subgroup of small-round-cell tumors defined by specific chimeric transcripts","volume":"331","author":"Delattre","year":"1994","journal-title":"N Engl J Med"},{"key":"R16-20251230","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/sj.onc.1200933","article-title":"A new member of the ETS family fused to EWS in Ewing tumors","volume":"14","author":"Peter","year":"1997","journal-title":"Oncogene"},{"key":"R17-20251230","first-page":"1229","article-title":"variant Ewing\u2019s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1","volume":"10","author":"Jeon","year":"1995","journal-title":"Oncogene"},{"key":"R18-20251230","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1098-2264(199602)15:2<115::AID-GCC6>3.0.CO;2-6","article-title":"Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy","volume":"15","author":"Kaneko","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"R19-20251230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/pbc.21596","article-title":"Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children\u2019s Oncology Group Bone Tumor Committee","volume":"51","author":"Meyer","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R20-20251230","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R21-20251230","first-page":"556","article-title":"A good response to induction chemotherapy in Ewing\/PNET tumors evaluated by imaging correlates both histological necrosis and survival. An Italian Sarcoma Group\/Scandinavian Sarcoma Group Study","volume":"18","author":"Picci","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"R22-20251230","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"R23-20251230","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R24-20251230","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/cncr.22821","article-title":"Analysis of prognostic factors in Ewing sarcoma family of tumors: review of St. Jude Children\u2019s Research Hospital studies","volume":"110","author":"Rodr\u00edguez-Galindo","year":"2007","journal-title":"Cancer"},{"key":"R25-20251230","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2106\/00004623-199807000-00011","article-title":"The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma","volume":"80","author":"Wunder","year":"1998","journal-title":"J Bone Joint Surg Am"},{"key":"R26-20251230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.28339","article-title":"Barriers to effective treatment of pediatric solid tumors in middle-income countries: can we make sense of the spectrum of nonbiologic factors that influence outcomes?","volume":"120","author":"Friedrich","year":"2014","journal-title":"Cancer"},{"key":"R27-20251230","first-page":"01.20.25320840","article-title":"Molecular characterization informs prognosis in patients with localized Ewing sarcoma: a report from the Children\u2019s Oncology Group","volume":"2025","author":"Gillani","year":"2025","journal-title":"medRxiv [Preprint]"},{"key":"R28-20251230","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/gcc.22828","article-title":"Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior","volume":"59","author":"Tsuda","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"R29-20251230","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.18632\/oncotarget.20098","article-title":"Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets","volume":"9","author":"Baldauf","year":"2018","journal-title":"Oncotarget"},{"key":"R30-20251230","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1092-9134(98)80042-7","article-title":"Synovial sarcoma","volume":"2","author":"Fisher","year":"1998","journal-title":"Ann Diagn Pathol"},{"key":"R31-20251230","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0046-8177(97)90254-9","article-title":"MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma\/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities","volume":"28","author":"Soslow","year":"1997","journal-title":"Hum Pathol"},{"key":"R32-20251230","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/cncy.22056","article-title":"NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls","volume":"126","author":"Russell-Goldman","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"R33-20251230","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/PAS.0b013e31824ee43c","article-title":"NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma","volume":"36","author":"Yoshida","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R34-20251230","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00428-021-03254-8","article-title":"Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?","volume":"480","author":"Machado","year":"2022","journal-title":"Virchows Arch"},{"key":"R35-20251230","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.3390\/cancers13081860","article-title":"Reverse engineering of Ewing sarcoma regulatory network uncovers PAX7 and RUNX3 as master regulators associated with good prognosis","volume":"13","author":"Ribeiro-Dantas","year":"2021","journal-title":"Cancers"},{"key":"R36-20251230","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(09)70286-4","article-title":"Ewing\u2019s sarcoma","volume":"11","author":"Balamuth","year":"2010","journal-title":"Lancet Oncol"},{"key":"R37-20251230","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1158\/2159-8290.CD-13-1037","article-title":"The genomic landscape of pediatric Ewing sarcoma","volume":"4","author":"Crompton","year":"2014","journal-title":"Cancer Discov"},{"key":"R38-20251230","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/pbc.25340","article-title":"Tumoral TP53 and\/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children\u2019s Oncology Group","volume":"62","author":"Lerman","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R39-20251230","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fonc.2013.00141","article-title":"Biomarkers in Ewing Sarcoma: the promise and challenge of personalized medicine. a report from the Children\u2019s Oncology Group","volume":"3","author":"Shukla","year":"2013","journal-title":"Front Oncol"},{"issue":"7-8","key":"R40-20251230","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cancergen.2014.08.004","article-title":"F. Ewing sarcoma mimicking atypical carcinoid tumor: detection of unexpected genomic alterations demonstrates the use of next generation sequencing as a diagnostic tool","volume":"207","author":"Doyle","year":"2014","journal-title":"Cancer Genet"},{"key":"R41-20251230","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00432-019-02895-2","article-title":"DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma","volume":"145","author":"Koelsche","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"R42-20251230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/path.5053","article-title":"Transcriptomic definition of molecular subgroups of small round cell sarcomas","volume":"245","author":"Watson","year":"2018","journal-title":"J Pathol"},{"key":"R43-20251230","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/PAS.0000000000000846","article-title":"Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases","volume":"41","author":"Antonescu","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R44-20251230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13000-021-01114-2","article-title":"Detection of BCOR gene rearrangement in Ewing-like sarcoma: an important diagnostic tool","volume":"16","author":"Li","year":"2021","journal-title":"Diagn Pathol"},{"key":"R45-20251230","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.prp.2017.08.002","article-title":"Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors","volume":"213","author":"Machado","year":"2017","journal-title":"Pathol Res Pract"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:00:49Z","timestamp":1767110449000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003145","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2025-06-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}